Document is current
Any future updates will be listed below
-
Authors
Máspero, Jorge F. https://orcid.org/0000-0001-9750-2346
Arnaout, Rand K. https://orcid.org/0000-0003-3951-5880
Vargas-Ramírez, Leslie https://orcid.org/0000-0001-6826-721X
Mobayed, Hassan https://orcid.org/0000-0002-7441-7621
Mahboub, Bassam https://orcid.org/0000-0002-6089-438X
Irani, Carla https://orcid.org/0000-0002-7706-3910
Bar-Shai, Amir https://orcid.org/0000-0003-3666-7360
Koh, Mariko S. https://orcid.org/0000-0002-1230-0129
Chao, Jason
Zaghloul, Sherif https://orcid.org/0009-0008-9756-1336
Kwah, Jason H. https://orcid.org/0000-0003-3119-4939
Dewhurst, Jennifer
Al-Ahmad, Mona S. https://orcid.org/0000-0003-2950-5363
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04550962 at ClinicalTrials.govDocuments that mention this clinical trial
Baseline Characteristics of Patients with Asthma Initiating Dupilumab in a Real-World Setting: The REVEAL Registry
https://doi.org/10.1007/s12325-026-03623-2
-
Funding
Funding for this research was provided by:
Sanofi (NCT12345678)
Regeneron Pharmaceuticals (NCT12345678)
- License Information
-
More Information
Article History
Received: 30 December 2025
Accepted: 21 April 2026
First Online: 10 June 2026
Declarations
:
: Jorge F. Máspero is a consultant for AstraZeneca and Sanofi; has received speaker fees from GSK, Menarini, Novartis, and Uriach; and has received research grants from Novartis. Rand K. Arnaout has received honoraria for serving as a speaker and on advisory boards from AllergoTek, AstraZeneca, Biologix, GSK, Novartis, Pfizer, Regeneron Pharmaceuticals Inc., Sanofi, and Takeda. Leslie Vargas-Ramírez has served as a speaker for AstraZeneca, Boehringer Ingelheim, and GSK. Hassan Mobayed and Bassam Mahboub have no conflicts of interest to disclose. Carla Irani has received honoraria from Novartis, Sanofi, and Stallergenes Greer. Amir Bar-Shai reports advisory board member/consulting fees, speaker fees, institutional research grants from AstraZeneca, Boehringer Ingelheim, GSK, Kamada, and Sanofi. Mariko S. Koh has received research support from AstraZeneca and reports lecture and advisory board honoraria paid to her institution from AstraZeneca, Boehringer Ingelheim, GSK, Novartis, Roche, and Sanofi. Jason Chao is a former employee of Sanofi and may hold stock and/or stock options in the company. Sherif Zaghloul and Jennifer Dewhurst are employees of Sanofi and may hold stock and/or stock options in the company. Jason H. Kwah is an employee and shareholder of Regeneron Pharmaceuticals Inc. Mona S. Al-Ahmad has received honoraria for serving as a speaker and on advisory boards from AstraZeneca, GSK, Novartis, and Sanofi.
: REVEAL is being conducted in accordance with the Declaration of Helsinki, the International Conference on Harmonisation Good Clinical Practice guideline, and applicable regulatory requirements. The REVEAL protocol was reviewed and approved by the respective institutional review boards before patient recruitment. All patients provided written informed consent. For patients under the age of 18 years, both parental/legal guardian consent and patient assent were required.
